• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » SpineGuard look to break even by 2018, promotes co-founder & CTO Bette to CEO

SpineGuard look to break even by 2018, promotes co-founder & CTO Bette to CEO

July 6, 2017 By Fink Densford

SpineGuard

SpineGuard  (EPA:ALSGD) said today it has implemented a profitability plan as it looks to break even by next year, and announced it would move its co-founder & CTO Stéphane Bette to the corner office, effective July 13.

In it’s pursuit of reaching a breakeven point, the company said it will concentrate its efforts in 2017 and 2018 on signing industry partnerships to expand the commercial applications of its DSG tech in the spinal and broader musculoskeletal sectors.

The company said it would also look to grow its worldwide sales with a focus on the US, as well as the implementation of a plan as it seeks to “right size its organization.”

“SpineGuard is a high-performing company with a cohesive team and a unique technology in DSG. We delivered double-digit growth this first half of the year in a context where we are preparing for the US launch of our smart DSG screw. I look forward to intensifying SpineGuard’s focus on leveraging our core DSG platform through additional deals in spine and other musculoskeletal segments while continuing to grow our organic sales, capitalizing on our strong commercial, marketing and clinical foundations and rebalancing the organization. In order to reach financial freedom, we have set a specific goal that SpineGuard reaches breakeven by the end of 2018 and then profitability,” Bette said in prepared remarks.

SpineGuard said its board of directors had named US GM, CTO and co-founder Bette as its new CEO, taking over for Pierre Jérôme, who will stay on the company’s board. Bette has led US operations at Spine Guard since 2009, and held a number of roles at SpineVision, the company said.

“The board is very pleased to appoint Stéphane as CEO to lead the company through its next stage of growth. He has led the company’s increasingly important US operations 2 since 2009 as well as overseen the development of SpineGuard’s core DSG technology platform. He is a natural successor to his co-Founder Pierre Jérôme, whom we warmly thank for his leadership of the company over the past 8 years. Under Pierre’s stewardship, SpineGuard has grown from a one-product company with €1 million in sales, through multiple fund-raising rounds, including an IPO in 2013, to the strong position it is in today. We are very pleased to have Pierre continue his association with the company in his role as Director with a particular focus on strategic and business development initiatives,” chair Alan Olsen said in a press release.

“After driving SpineGuard with close support from Stéphane since its inception, I am particularly glad to hand over the baton to him now – when momentum is building for the company with sustained growth, promising perspectives in China and the further deployment of our DSG technology platform in spine and dental through our partnership strategy. This smooth transition will provide continuity for our employees, customers and partners,” Jérôme said in a prepared statement.

Last June, SpineGuard said it won FDA 510(k) clearance for its PediGuard threaded Dynamic Surgical Guidance device designed for pedicle screw insertion.

Filed Under: Business/Financial News Tagged With: SpineGuard

More recent news

  • Autonomix picks up key nerve ablation catheter patent
  • Affluent Medical can move to pivotal phase of artificial urinary sphincter study
  • Globus Medical announces $500M share repurchase program
  • Cook Medical warns of issue with angiographic catheter
  • Virtuoso Surgical reports first cases with robotic endoscopy system, plans FDA IDE submission

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy